Business Standard

Outcome of board meeting of Mavens Biotech

Image

Capital Market

Held on 25 July 2014

Mavens Biotech announced that the Board of Directors of the Company at its meeting held on 25 July 2014, inter alia, transacted the following but same subject to the approval of members at 32nd Annual General meeting of the Company:

(a) Adoption of statement of Profit and Loss, Balance Sheet, Report of Board of Directors and Auditors for the year ended 31 March 2014.

(b) Appointment of Auditors and fixing their Remuneration.

(c) Appointment of H. M. Singhi as an Independent Director.

(d) Appointment of N. B. Ranabat as an Independent Director.

(e) Based on the recommendations of the Nomination and Remuneration Committee, Chandrakala Devi Lakhotia has been co-opted as Additional Director (Independent Directors) of the Company with effect from 25 July 2014.

 

(f) Approved the re-appointment MBharat Kumar Sah as Whole time Director of the Company with effect from 01 August 2014.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 01 2014 | 5:47 PM IST

Explore News